(2026). Cost-effectiveness of using Intravenous Ferric Carboxymaltose compared to Intravenous Iron Sucrose for treatment of iron deficiency anemia in pregnancy. Health Economics Review.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Cost-effectiveness of Using Intravenous Ferric Carboxymaltose Compared to Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pregnancy."
Health Economics Review 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Cost-effectiveness of Using Intravenous Ferric Carboxymaltose Compared to Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pregnancy."
Health Economics Review, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.